Oral anticoagulants--the totem and the taboo.
作者信息
Breckenridge A
出版信息
Br Med J. 1976 Feb 21;1(6007):419-23. doi: 10.1136/bmj.1.6007.419.
Abstract
摘要
相似文献
1
Oral anticoagulants--the totem and the taboo.
Br Med J. 1976 Feb 21;1(6007):419-23. doi: 10.1136/bmj.1.6007.419.
2
Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).
Clin Sci. 1971 Apr;40(4):351-64. doi: 10.1042/cs0400351.
3
Clinical implications of enzyme induction.
Ann N Y Acad Sci. 1971 Jul 6;179:421-31. doi: 10.1111/j.1749-6632.1971.tb46919.x.
4
Influence of nitrazepam on oral anticoagulation with phenprocoumon.
Clin Pharmacol Ther. 1972 May-Jun;13(3):361-5. doi: 10.1002/cpt1972133361.
5
Apparent resistance to oral anticoagulant therapy and influence of hypnotics on some coagulation factors.
Acta Med Scand. 1968 Oct;184(4):297-300. doi: 10.1111/j.0954-6820.1968.tb02461.x.
6
Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.
Clin Sci. 1969 Oct;37(2):565.
7
The effects of oral sedatives on the vasoconstrictive reaction to fear.
Br J Anaesth. 1971 Apr;43(4):380-4.
8
Drugs affecting blood coagulation and hemostasis.
Int Anesthesiol Clin. 1985 Summer;23(2):103-23. doi: 10.1097/00004311-198523020-00010.
9
[Changed warfarin tolerance].
Tidsskr Nor Laegeforen. 1973 Jun 10;93(16):1236-9.
10
The clinical choice of sedative-hypnotics.
Ann Intern Med. 1972 Jul;77(1):91-100. doi: 10.7326/0003-4819-77-1-91.
引用本文的文献
1
Clinical relevance of pharmacokinetics.
Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001.
2
Interindividual differences in the response to oral anticoagulants.
Drugs. 1977 Nov;14(5):367-75. doi: 10.2165/00003495-197714050-00003.
本文引用的文献
1
Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur.
Lancet. 1959 Dec 5;2(7110):981-9. doi: 10.1016/s0140-6736(59)91464-3.
2
Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial.
Lancet. 1960 May 7;1(7132):995-8. doi: 10.1016/s0140-6736(60)90885-0.
3
SOME ASPECTS OF THE FATE AND RELATIONSHIP OF THE N-METHYL GROUP OF MORPHINE TO ITS PHARMACOLOGICAL ACTIVITY.
J Med Chem. 1963 May;6:237-46. doi: 10.1021/jm00339a005.
4
VITAMIN K INDUCED PROTHROMBIN FORMATION: ANTAGONISM BY ACTINOMYCIN D.
Science. 1964 Aug 28;145(3635):926-8. doi: 10.1126/science.145.3635.926.
5
Cerebrovascular disease: trial of long-term anticoagulant therapy.
Br Med J. 1962 Oct 20;2(5311):1003-6. doi: 10.1136/bmj.2.5311.1003.
6
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.
Lancet. 1960 Jun 18;1(7138):1309-12. doi: 10.1016/s0140-6736(60)92299-6.
7
The discovery of dicumarol and its sequels.
Circulation. 1959 Jan;19(1):97-107. doi: 10.1161/01.cir.19.1.97.
8
An evaluation of anticoagulant therapy in acute myocardial infarction.
Scott Med J. 1956 Jan;1(1):1-14. doi: 10.1177/003693305600100101.
9
The effect of various drugs on the binding of warfarin-14C to human albumin.
Biochem Pharmacol. 1967 Jul 7;16(7):1219-26. doi: 10.1016/0006-2952(67)90153-0.
10
Rapid fluorometric assay for plasma warfarin.
Clin Chem. 1967 Feb;13(2):126-31.
Zotero 插件